Multidisciplinary expert consensus on treatment intensification in metastatic androgen pathway modulation-sensitive prostate cancer: a case-based RAND/UCLA analysis

Ángel Borque-Fernando, Teresa Alonso-Gordoa, María José Juan-Fita, Fernando Lopez Campos, Daniel Adolfo Pérez-Fentes, Antoni Vilaseca, Cristina Moretones Agut, Paola Usán, Pablo Maroto Rey

Open source

DOI
10.7573/dic.2026-6-2
Published
2026-09-07
Container
Drugs in Context
Publisher
BioExcel
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7573/dic.2026-6-2,
  title = {Multidisciplinary expert consensus on treatment intensification in metastatic androgen pathway modulation-sensitive prostate cancer: a case-based RAND/UCLA analysis},
  author = {Ángel Borque-Fernando and Teresa Alonso-Gordoa and María José Juan-Fita and Fernando Lopez Campos and Daniel Adolfo Pérez-Fentes and Antoni Vilaseca and Cristina Moretones Agut and Paola Usán and Pablo Maroto Rey},
  year = {2026},
  journal = {Drugs in Context},
  doi = {10.7573/dic.2026-6-2},
  url = {https://doi.org/10.7573/dic.2026-6-2}
}

RIS

TY  - JOUR
TI  - Multidisciplinary expert consensus on treatment intensification in metastatic androgen pathway modulation-sensitive prostate cancer: a case-based RAND/UCLA analysis
AU  - Ángel Borque-Fernando
AU  - Teresa Alonso-Gordoa
AU  - María José Juan-Fita
AU  - Fernando Lopez Campos
AU  - Daniel Adolfo Pérez-Fentes
AU  - Antoni Vilaseca
AU  - Cristina Moretones Agut
AU  - Paola Usán
AU  - Pablo Maroto Rey
PY  - 2026
JO  - Drugs in Context
DO  - 10.7573/dic.2026-6-2
UR  - https://doi.org/10.7573/dic.2026-6-2
ER  - 

APA

Borque-Fernando, Á., Alonso-Gordoa, T., Juan-Fita, M. J., Campos, F. L., Pérez-Fentes, D. A., Vilaseca, A., Agut, C. M., Usán, P., & Rey, P. M. (2026). Multidisciplinary expert consensus on treatment intensification in metastatic androgen pathway modulation-sensitive prostate cancer: a case-based RAND/UCLA analysis. Drugs in Context. https://doi.org/10.7573/dic.2026-6-2

Source records